IRadimed Corp PT receives Investment Bank Analyst Rating Update
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Consumer Services, Oil & Gas and Technology sectors led shares higher while losses in the Basic...
Investing.com – U.S. stocks were lower after the close on Tuesday, as losses in the Telecoms, Utilities and Technology sectors led shares lower. At the close in NYSE, the Dow...
IRADIMED CORPORATION. (NASDAQ:IRMD) reported fourth-quarter 2018 adjusted earnings per share (EPS) of 16 cents, up 60% year over year. This figure surpassed the Zacks Consensus...
For today’s bulletin, we take a look at our latest STRONG BUY and BUY upgrades. We also provide a link to download a FREE STOCK REPORT on Esterline Technologies Corporation...
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
|Average||43.50 (+45.88% Upside)|
|No. of Analysts||2|